The influence of alloxan diabetes on experimental cancer

. 1968 Mar;22(1):128–132. doi: 10.1038/bjc.1968.18

The influence of alloxan diabetes on experimental cancer.

PMCID: PMC2008221 PMID: 5642997

These references are in PubMed. This may not be the complete list of references from this article.

CHAN P. Y., HADDEN D. H., McDONALD G. O., COLE W. H. The use of "aging" in reducing the development of tumors after inoculation of carcinosarcoma 256 Walker cells. Cancer. 1961 Sep-Oct;14:1057–1059. doi: 10.1002/1097-0142(196109/10)14:5<1057::aid-cncr2820140522>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
Caridis D. T., Blair D. W., Kilpatrick S. J., Carr A. J. The effect of alloxan on gastric secretion. Scott Med J. 1966 Jul;11(7):247–249. doi: 10.1177/003693306601100704. [DOI] [PubMed] [Google Scholar]
RODIN A. E., TURNER F. W., COUVES C. M. INFLUENCE OF ISOLATION PERFUSION WITH AN ALKYLATING AGENT ON THE HISTOPATHOLOGY AND METASTATIC PROPENSITY OF WALKER-256 CARCINOMA. Can J Surg. 1963 Oct;6:489–498. [PubMed] [Google Scholar]
SCHWARTZ M. A biomathematical approach to clinical tumor growth. Cancer. 1961 Nov-Dec;14:1272–1294. doi: 10.1002/1097-0142(196111/12)14:6<1272::aid-cncr2820140618>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]